Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM
Abstract Renal fibrosis is a common pathological feature and outcome of almost all chronic kidney diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis. Mesenchymal stem cell-derived exosomes (MSC-Exos) have been proposed as a promising therapeutic approach for renal...
Main Authors: | Shihao Xu, Yin Celeste Cheuk, Yichen Jia, Tian Chen, Juntao Chen, Yongsheng Luo, Yirui Cao, Jingjing Guo, Lijun Dong, Yi Zhang, Yi Shi, Ruiming Rong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-10-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-05305-7 |
Similar Items
-
The role of S-nitrosylation of PFKM in regulation of glycolysis in ovarian cancer cells
by: Wenwen Gao, et al.
Published: (2021-04-01) -
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
by: Min Zhou, et al.
Published: (2022-07-01) -
Periosteum-derived mesenchymal stem cell alleviates renal fibrosis through mTOR-mediated Treg differentiation
by: Yongsheng Luo, et al.
Published: (2023-12-01) -
Monocytic Myeloid-Derived Suppressor Cells Inhibit Myofibroblastic Differentiation in Mesenchymal Stem Cells Through IL-15 Secretion
by: Yin Celeste Cheuk, et al.
Published: (2022-02-01) -
NAT10 mediated ac4C acetylation driven m6A modification via involvement of YTHDC1-LDHA/PFKM regulates glycolysis and promotes osteosarcoma
by: Zhongting Mei, et al.
Published: (2024-01-01)